Metastatic Ovarian Cancer

Disease

Related News

Related Clinical Trials

NCT ID Title Status Phase
NCT07755436

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

RECRUITING PHASE1
NCT07718854

Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer

NOT_YET_RECRUITING PHASE2
NCT01174121

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

RECRUITING PHASE2